RHLD:NYSEResolute Holdings Management Analysis
Data as of 2026-05-19 - not real-time
$106.55
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Resolute Holdings is trading well below its short‑ and medium‑term moving averages, signaling a sustained downtrend despite a recent price rebound toward a key support zone. The Relative Strength Index sits in the oversold region, while the MACD line remains under the signal line, producing a bearish histogram that suggests further downside pressure. Volatility is extremely high and beta is significantly above one, indicating that price swings are amplified relative to the broader market. Fundamental metrics reveal a price‑to‑book ratio that is astronomically elevated, dwarfing peers, while the price‑to‑earnings multiple is modestly below the industry average, creating a mixed valuation picture. Operating margins are negative and free cash flow is in the red, compounded by a debt load that dwarfs the company’s equity base, raising concerns about financial resilience. The firm does not pay a dividend, eliminating any income cushion for shareholders.
The limited press coverage consists mainly of corporate announcements without substantive earnings guidance, offering little new catalyst. With liquidity modestly improving but still below average for its market cap, and with no clear path to improving cash generation, the risk profile remains high. Given the confluence of bearish technical signals, an overvalued balance sheet, and weak operating fundamentals, the outlook is cautious across horizons.
The limited press coverage consists mainly of corporate announcements without substantive earnings guidance, offering little new catalyst. With liquidity modestly improving but still below average for its market cap, and with no clear path to improving cash generation, the risk profile remains high. Given the confluence of bearish technical signals, an overvalued balance sheet, and weak operating fundamentals, the outlook is cautious across horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- bearish MACD divergence
- RSI approaching oversold territory
- price hovering just above a near‑term support level
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- price-to-book ratio far above industry norms
- high leverage combined with negative free cash flow
- persistent volatility and weak price momentum
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- ongoing operating losses and thin margins
- excessive debt relative to equity
- absence of dividend and limited cash generation prospects
Key Metrics & Analysis
Financial Health
Revenue Growth292.50%
Profit Margin7.70%
P/E Ratio15.5
ROE1.23%
ROA2.15%
Debt/Equity70.98
P/B Ratio138.4
Op. Cash Flow$60.9M
Free Cash Flow$-58210000
Industry P/E29.1
Technical Analysis
TrendNeutral
RSI32.1
Support$97.88
Resistance$145.35
MA 20$124.46
MA 50$140.55
MA 200$138.88
MACDBearish
VolumeIncreasing
Fear & Greed Index89.09
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta2.17
Volatility86.38%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.